Andrea Degasperi, PhD, University of Cambridge, Cambridge, UK, provides an overview of an investigation into the whole-genome sequences (WGS) of more than 12,000 tumors, revealing previously unreported mutational signatures and providing new insight into the cause of cancer. This interview took place at the Molecular Analysis for Precision oncology (MAP) Congress 2022 in Amsterdam, Netherlands.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.”